UBS Starts Ortho Clinical Diagnostics (OCDX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Morgan Stanley Starts Ortho Clinical Diagnostics (OCDX) at Overweight
February 22, 2021 3:08 AM ESTMorgan Stanley analyst Tejas Savant initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Overweight rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More
Goldman Sachs Starts Ortho Clinical Diagnostics (OCDX) at Buy
February 22, 2021 1:19 AM ESTGoldman Sachs analyst Matthew Sykes initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More
JPMorgan Starts Ortho Clinical Diagnostics (OCDX) at Overweight
February 22, 2021 12:47 AM ESTJPMorgan analyst Tycho Peterson initiates coverage on Ortho Clinical Diagnostics (NASDAQ: OCDX) with a Overweight rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Ortho Clinical Diagnostics... More
